NWCI (NWCI) Stock Price & Analysis
NWCI (NWCI) rose 0.00% to USD 0 as of June 10, 2026 at 14:11 UTC, according to Nexqual real-time market data.
NWCI last closed at USD 0; the session ranged USD 0–0 on volume of 4,000 shares. Market capitalization is $3,314, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 14:11 UTC.
Key Statistics (as of June 10, 2026 at 14:11 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 4,000 shares |
| Market Cap | $3,314 |
| Exchange | PNK |
Technical Analysis (NWCI)
Nexqual's technical model rates NWCI "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 14:11 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (NWCI)
Wall Street analysts rate NWCI "None", per Nexqual as of June 10, 2026 at 14:11 UTC.
| Consensus Rating | None |
|---|
Earnings (NWCI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2011-09-30 | USD -0.07 vs est -0.08 ▲ beat |
| 2011-06-30 | USD -0.03 vs est -0.07 ▲ beat |
| 2011-03-31 | USD -0.08 vs est -0.09 ▲ beat |
| 2010-12-31 | USD -0.11 vs est -0.08 ▼ miss |
Source: Nexqual, June 10, 2026 at 14:11 UTC.
Financials & Fundamentals (NWCI)
| Total Revenue | $238,582 |
|---|---|
| Revenue Growth (YoY) | -90.00% |
| Gross Margin | +29.68% |
| Operating Margin | -15765.37% |
| Profit Margin | +0.00% |
| Current Ratio | 0.01 |
| Total Cash | $13,064 |
| Total Debt | $4.16M |
| Free Cash Flow | $5.30M |
Source: Nexqual, June 10, 2026 at 14:11 UTC.
Financial Health Score (NWCI)
Nexqual rates NWCI's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 14:11 UTC.
| Growth | Critical — Revenue -90% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $13K cash vs $4M debt |
| Cash Flow | Strong — FCF $5M, 2057% margin |
| Efficiency | Mixed — No data |
Ownership (NWCI)
| Shares Outstanding | 33.15M |
|---|
Source: Nexqual, June 10, 2026 at 14:11 UTC.
Leadership (NWCI)
NWCI is led by Jess Emery Jones (age 46), CEO & Director, per Nexqual as of June 10, 2026 at 14:11 UTC.
| CEO & Director | Jess Emery Jones (age 46) |
|---|---|
| Chief Operating Officer | Greg Sadowski |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| POSC | Positron Corp. | USD 1.86 | ▼ 1.59% |
| LTUS | Lotus Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| PUMD | PROUROCARE MEDICAL INC | USD 0 | ▲ 0% |
| PDMI | Paradigm Medical Industries, In | USD 0 | ▲ 0% |
| NIMU | Non-Invasive Monitoring Systems | USD 0.06 | ▼ 14.29% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 14:11 UTC. This page is informational and not investment advice.